IDH2 and neoplasm: However, our IDH‐mutant tumours had no excess of CMS3, a CRC subtype associated with mucinous cancers and KRAS mutations (OR = 0.25; 95% CI = 0.04–1.49; p = 0.15; supplementary material, Table S3) [33].